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The Mid-Atlantic Ethics Committee 
Newsletter is a publication of the 
Maryland Health Care Ethics 
Committee Network, an initiative 
of the University of Maryland 
Francis King Carey School of Law’s 
Law & Health Care Program. The 
Newsletter combines educational 
articles with timely information 
about bioethics activities. Each issue 
includes a feature article, a Calendar 
of upcoming events, and a case 
presentation and commentary by local 
experts in bioethics, law, medicine, 
nursing, or related disciplines. 
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In 1998, the American Society for Bio-
ethics and Humanities (ASBH) published 
the first edition of the Core Competen-
cies for Health Care Ethics Consultation. 
The Task Force for Standards on Bioeth-
ics Consultation recommended that the 
Core Competencies be used as voluntary 
guidelines, and discouraged movement 
toward “professionalizing” ethics con-
sultants (for example, through individual 
certification and program accreditation). 
However, the field of ethics consultation 
continues to evolve, with several post-
graduate programs and clinical fellow-
ships available to educate and train ethics 
consultants. In 2011, ASBH published 
the second edition of the Core Compe-
tencies, in which the movement toward 
professionalizing the field of health care 
ethics (HCE) consultation was recog-
nized, rather than discouraged. A small 
but growing number of HCE consultants 
have advocated for moving their field 
forward by developing a Code of Ethics, 
certification of ethics consultants, and 
accreditation of programs that train ethics 
consultants. 
ASBH has responded. Its Clinical Eth-
ics Consultation Affairs (CECA) Stand-
ing Committee is developing a Code of 
Ethics for Health Care Ethics Consultants 
(see Box). ASBH is currently collaborat-
ing with Eric Kodish, a physician and 
ethics consultant at the Cleveland Clinic, 
who was recently awarded a grant from 
the Josiah Macy, Jr. Foundation to sup-
port a project entitled, “Toward Consen-
CODE OF ETHICS & QUALITY 
ATTESTATION FOR ETHICS CONSULTANTS
sus: Quality Attestation for Clinical Eth-
ics Consultants.” ASBH’s position is that 
all individuals who do HCE consultation 
should be held accountable to the stan-
dards outlined in the Core Competencies. 
However, only individuals functioning 
at an advanced level—particularly those 
doing solo HCE consultations—would 
pursue the “Quality Attestation,” which 
would be a step toward a more formal 
certification process in the future.
Members of the Core Competencies 
Update Task Force (which authored the 
second edition of the Core Competen-
cies) recognize that most individuals 
doing HCE consultation do not consider 
themselves to be professional HCE 
consultants. However, the Task Force 
believes that running an effective ethics 
consultation service typically requires 
having access to at least one individual 
with advanced-level HCE consultation 
competency. Toward that end, efforts to-
ward professionalizing HCE consultants 
will hopefully not displace health care 
providers who wish to remain involved 
in ethics activities at their institutions, 
but instead, will ensure that there are 
enough expert HCE consultants to help 
run ethics programs at health care orga-
nizations throughout the country. The 
goal is that this should make it easier, 
not harder, for those who want to stay 
involved in HCE consultation activi-
ties at their institutions to do so without 
feeling overburdened.  But this will 
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The information in this newsletter
is not intended to provide legal 
advice or opinion and should not be 
acted upon without consulting an 
attorney.
consultants, some individuals are also 
members of other professions and may 
be accountable to different codes of 
ethics. While engaging in HCE con-
sultation, individuals should adhere to 
this statement of responsibilities.
Professional Responsibilities
Be competent: HCE consultants 
should practice in a manner consistent 
with recognized standards of excel-
lence. 
Avoid conflicts of interest: HCE 
consultants have an obligation to prop-
erly manage conflicts of interest, i.e., 
situations in which the professional 
judgment of a HCE consultant may 
appear to be affected or compromised 
by a personal or financial interest, es-
pecially in a way that might adversely 
affect recommendations regarding pa-
tient care. If it is not possible to avoid 
a conflict of interest through recusal or 
referral, HCE consultants have an obli-
gation to be transparent and make full 
disclosure to all the involved parties 
of the nature of the conflict, maintain 
their independence, remain unbiased, 
and to exercise good professional 
judgment.
Avoid conflicts of obligation: HCE 
consultants should identify, disclose, 
strive to avoid and manage within 
ethically appropriate means those 
conflicting obligations that arise when 
they perform multiple roles within an 
organization. Consultants may need 
only happen if health care administra-
tors and corporate leaders realize the 
value of having an ethics consultant 
with recognized expertise in charge of 
their health care organization’s ethics 
program. Below is the Draft Code of 
Ethics for Health Care Ethics Consul-
tants prepared by the ASBH Clinical 
Ethics Consultation Affairs Standing 
Committee.
Draft Code of Ethics for Health 
Care Ethics Consultants
Preface: This statement sets out the 
core ethical responsibilities of anyone 
engaged in health care ethics (HCE) 
consultation. HCE consultation is ‘a 
set of services provided by an individ-
ual or group in response to questions 
from patients, families, surrogates, 
health care professionals, or other 
involved parties who seek to resolve 
uncertainty or conflict regarding value-
laden concerns that emerge in health 
care’ (ASBH CC TF, 2011). The goals 
of HCE consultation include identi-
fying, clarifying and analyzing the 
ethical issues that underlie the consul-
tation request. HCE consultation seeks 
to facilitate agreement among involved 
parties about ethically justifiable op-
tions. HCE consultation addresses the 
ethical concerns of persons involved 
in health care decision making and 
medical research, including patients, 
families, and providers, and those who 
set guidelines and create policies.
In addition to their role as HCE 
Code of Ethics 
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Be a part of the process! Provide your thoughts and comments to 
drafters of the Code at a special workshop at the ASBH Annual 
Meeting on Friday, October 19, 1-2:30 PM, at the Hyatt Regency 
on Capital Hill in Washington D.C. The ASBH Annual Meeting 
"Representing Bioethics" offers pre-conference sessions, concur-
rent and plenary sessions from October 18-21. It alternates cities 
so take advantage of its proximity and consider attending this 
year! See http://www.asbh.org to view the full program.
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to recuse themselves when conflicts 
of obligation cannot be appropriately 
managed.
Protect confidentiality: HCE 
consultants should recognize when 
information is personal, respecting and 
protecting privacy with confidential-
ity, and only sharing such information 
with discretion in accordance with 
standards of ethics, law, and organiza-
tional policy.
Promote integrity: HCE consul-
tants should cultivate attitudes and at-
tributes that support reflective practice 
and promote personal and professional 
integrity.
Make responsible public state-
ments: When addressing the lay pub-
lic about HCE issues, HCE consultants 
should speak responsibly.
Contribute to the field: HCE 
consultants should participate in the 
advancement of the field through 
contributions to practice, education, 
administration, knowledge, and/or 
skill development.
Promote just health care: HCE 
consultants should collaborate with 
other professionals and lay persons to 
promote a more equitable health care 
system.
MHECN CO-SPONSORS COMMUNICATIONS CONFERENCE 
WITH CARROLL HOSPITAL CENTER
On June 13, 2012, MHECN col-
laborated with Carroll Hospital Center 
to hold a workshop entitled, “Navi-
gating Communication Landmines in 
Ethics Consultation.”  The workshop 
was co-developed by Lucia Wocial, 
Ph.D., R.N., Nurse Ethicist with The 
Fairbanks Center for Medical Ethics 
(FCME) at Indiana University Health 
and Sandra Petronio, Ph.D., Professor 
in the Department of Communication 
Studies, senior affiliate faculty with 
FCME, and Core Faculty of the Indi-
ana University Center for Bioethics. 
Dr. Wocial presented at the work-
shop, incorporating concepts adapted 
from the work of Drs. Ann Cook and 
Helena Hoas, who direct the National 
Rural Bioethics Project at the Univer-
sity of Montana (http://www.umt.edu/
bioethics/ ).  Cook and Hoas discov-
ered that health care providers in rural 
settings were not troubled as much by 
“ethical problems” and dilemmas of-
ten featured by academic bioethicists. 
Rather, they were troubled by conflicts 
arising when health care providers 
from different disciplines disagreed 
with each other when trying to make 
health care decisions.  Wocial adapted 
a script from the National Rural 
Bioethics Project’s Reader’s Theater, 
in which characters play out a scene 
demonstrating various communication 
landmines.
The workshop focused on the 
following ethics consultation skills 
identified in the Core Competencies 
for Health Care Ethics Consultation  
(ASBH, 2011): 
• Listen well, communicate inter-
est, respect, support and empa-
thy to involved parties.
• Enable the involved parties to 
communicate effectively and be 
heard by other parties.
• Recognize and attend to vari-
ous relational barriers to com-
munication.
Anyone who has done ethics con-
sultation knows that communication 
breakdown is at the root of many, if 
not most, ethics consultation requests. 
This likely stems from a definitional 
feature of communication that Dr. 
Wocial underscored in her introduc-
tory presentation: communication is 
the response you get from the message 
you send regardless of your intent. Dr. 
Wocial reviewed the following five 
core communications competencies:
• Communicative Adaptability:  
Remaining composed during 
communication interactions 
and responding appropriately 
through confirmatory statements 
based on others’ perceptions and 
understanding of the situation 
(e.g., “You did the right thing by 
asking for help.”).
• Conversational Involvement: 
Being responsive, perceptive, 
and attentive to what others in 
the encounter are communicat-
ing, without minimizing what 
they feel is important, while 
paying attention to meta-mes-
sages (e.g., “I can see you’re 
angry that your blood had to be 
redrawn.”). 
• Conversational Management:  
Taking appropriate turns when 
speaking and avoiding un-
necessary interruptions, asking 
meaningful questions, and being 
attentive to non-verbal messages 
(e.g., “You say that you’re not 
angry but you seem upset to me. 
Are you upset? … Can you tell 
me more about that?”).
• Empathy: Listening attentively 
and reacting to the person’s 
emotional state, offering tis-
sues if the person is crying, 
not changing the topic merely 
to reduce emotional intensity, 
showing warmth and caring via 
verbal and non-verbal messages 
(e.g., “Oh my, you’ve been 
Cont. on page 4
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through so much this last month. 
I’m so sorry.”).
• Respect and Expectations:  Pay-
ing attention to those involved 
in the communication encoun-
ter and respecting different 
points of view. Looking for the 
meta-communication issues to 
identify the way individuals 
involved are framing the issues 
and taking them into account.
Workshop attendees then reviewed 
specific “communication landmines” 
that can derail an effective ethics 
consultation (as well as other com-
munication encounters). These include 
“negative messaging” that makes peo-
ple involved feel unimportant, disre-
spected, undervalued, or insignificant. 
For example, implicit or explicit state-
ments may dismiss or discount another 
person’s credibility or point of view. 
Other examples of “negative mes-
saging” include defensive behaviors 
(e.g., being judgmental, controlling, 
unemotional, or inflexible), relational 
barriers (e.g., jumping to conclusions, 
being hostile), and listening barriers 
(e.g., avoiding difficult topics, being 
closed-minded, bored, inattentive, or 
insincere). 
The ethics consultant should obvi-
ously avoid displaying these negative 
messages, but more commonly, should 
recognize them and respond when 
others involved in an ethics consulta-
tion exhibit negative messaging during 
the consultation process. Strategies 
involve disarming these communica-
tion landmines by counteracting the 
negative messaging with “confirming” 
messaging. For example, say during 
an ethics consultation group meeting, 
the patient’s adult daughter says, “My 
brother (Joe) doesn’t care about my 
mom. He never comes to see her.” The 
ethics consultant could disarm such a 
remark through a confirming message, 
such as, “Joe 
is here with us 
now. Let’s hear 




iors during ethics 
consultation can 
be challenging, 
as these often 
arise from un-
derlying emo-
tional turmoil of 
the individuals 
involved.  It’s 
important to be 
astutely aware of 





that affect one’s 
vocal tone, posture, facial expressions, 
hand gestures, etc. The aim here is for 
“bounded emotionality” -  that is, ac-
knowledging emotions that come up, 
expressing them constructively (e.g., 
“You seem sad” … “I feel frustrated 
when you …”), and at the same time, 
exercising control over them.  Disarm-
ing relational and listening barriers 
involves various strategies to gain 
trust and connect with individuals in 
the communication encounter.
Most health care professionals have 
received some education or training 
on effective communication strategies. 
Yet, there are too few opportunities 
to hone these skills, particularly as 
they relate to ethics consultation. At 
the workshop, volunteer actors read 
through two scripted scenes based on 
a case study involving a 72 year old 
hospitalized woman at the center of 
an ethics consultation: one involving 
one-on-one conversations between the 
ethics consultant and various involved 
parties, and another involving a group 
meeting with involved parties. The 
involved parties included: the patient’s 
primary physician, ER physician, 
primary nurse, social worker, chaplain, 
adult daughter, and adult son. Work-
shop attendees tried to spot the land-
mines and took turns trying to disarm 
them with the strategies Dr. Wocial 
presented.  Attendees were enthusi-
astic about this interactive method of 
practicing advanced communication 
skills. 
If you are interested in using the 
workshop case study and script for a 
training session at your facility, con-
tact Anita Tarzian at (410) 706-1126, 
atarzian@law.umaryland.edu. 
(from l to r:) Anita Tarzian, PhD, RN, MHECN Program Coor-
dinator; chaplain Angela Boggs, Manager of the Spiritual Care 
Department at CHC; Diane Hoffmann, MHECN Executive Direc-
tor and Professor of Law at the University of Maryland School of 
Law; Lucia Wocial, PhD, RN, nurse ethicist at Indiana University 
Health Charles Warren Fairbanks Center for Medical Ethics; and 
Kevin Smothers, M.D., F.A.C.E.P., Senior Vice Presient of Medical 
Affairs and Chief Medical and Quality Officer at CHC.
Conference 
Cont. from page 3
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DHMH RESPONDS TO MOLST FEEDBACK
Maryland Medical Orders for Life 
Sustaining Treatment (MOLST) is a 
portable and enduring form for orders 
about cardiopulmonary resuscitation 
and other life-sustaining treatments. 
MOLST regulations were proposed 
in the September 23, 2011 Maryland 
Register, with the public comment 
period ending October 24, 2011. The 
Department of Health and Mental 
Hygiene (DHMH) summarized the 
comments they received in the August 
10, 2012 issue of the Maryland Regis-
ter. These comments and responses are 
excerpted from The Maryland Regis-
ter, 39(16), August 10, 2012, 1087-89. 
Comment: Several comments 
emphasized the value of patient 
decision making in health care 
and urged DHMH to issue regula-
tions to implement MOLST.
Response: DHMH is proposing 
these regulations to implement 
MOLST and support patient au-
tonomy in key health care decisions. 
Because DHMH highly values the 
input of affected organizations 
and individuals, the Department 
accepted public comment on the 
initial proposal. DHMH is accepting 
public comments on this proposal as 
well.
Comment: Several comments 
recommended providing time for 
training and preparation prior to 
implementation of the MOLST 
regulation.
Response: DHMH agrees with this 
comment. The final MOLST regula-
tion will provide time for training 
and preparation. 
Comment: Several comments 
expressed concern that under cer-
tain circumstances, the MOLST 
is inappropriate and could affect 
the trust between the provider 
and the patient. Specifically, com-
ments recommended that MOLST 
should not be required for pa-
tients whose primary diagnosis is 
related to pregnancy, children un-
der age 18 with non-life threaten-
ing conditions, and patients with a 
primary psychiatric diagnosis.
Response: The proposed regulations 
exempt these three populations from 
the requirement that their physicians 
fill out a MOLST form. Physicians 
caring for these patients may elect 
to fill out a MOLST form, depending 
on the circumstances and the vol-
untary participation of the patient. 
In addition, the training for MOLST 
includes education for health care 
providers about discussing life-
sustaining treatment decisions with 
a patient or authorized decision 
maker.
Comment: A comment noted that 
the completion of a MOLST form 
should always be based on volun-
tary participation from the patient 
or the patient‘s authorized deci-
sion maker. 
Response: DHMH agrees with the 
comment. The proposed MOLST 
form already includes the following 
language: 
“Mark this line if the patient or 
authorized decision maker declines 
to discuss or is unable to make a 
decision about these treatments. 
The patient‘s or authorized decision 
maker‘s participation in the prepa-
ration of the MOLST form is always 
voluntary. If the patient or autho-
rized decision maker has not limited 
care, except as otherwise provided 
by law, CPR will be attempted and 
other treatments will be given.”
Comment: Several comments 
expressed concern about the lan-
guage on the form related to medi-
cal effectiveness and the Health 
Care Decisions Act. This legal 
path is rare in Maryland and must 
be substantiated with appropriate 
documentation.
Response: DHMH recognizes that 
medical ineffectiveness is a rarely 
used path in Maryland. Based on 
the comments, the proposed regula-
tion rewords the language related to 
the Health Care Decisions Act and 
makes reference to the requirement 
for appropriate documentation in 
the medical record. The proposal, 
however, does not drop all men-
tion of the Health Care Decisions 
Act from the MOLST form, on the 
grounds that (1) Existing EMS 
forms provide an option to docu-
ment an order based on this path, 
and MOLST should be consistent 
with current practice and (2) the 
MOLST legislation anticipates that 
the MOLST form can serve as a 
single pathway for orders regarding 
life-sustaining treatments. 
Comment: A comment stated that 
to be consistent with the Health 
General Article, the MOLST 
regulation should state consis-
tently that a health care facility 
shall, “On request of the patient, 
offer any physician or nurse prac-
titioner selected by the patients 
the opportunity to participate in 
updating or completing the form.” 
Response: DHMH agrees. The pro-
posed regulation states: 
E. When initially completing a 
MOLST form or updating an exist-
ing MOLST form, a health care 
facility shall:
(1) Offer the patient or authorized 
decision maker the opportunity to 
participate in completing or updat-
ing the MOLST form, and on request 
of the patient, offer any physician 
or nurse practitioner selected by the 
patient the opportunity to partici-
pate in updating or completing the 
MOLST form.
In addition to the above changes, 
the proposed regulation corrects the 
website address, clarifies a state-
ment related to maintenance of the 
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MOLST form in the patient‘s active 
medical record, deletes the phrase 
“Blank order forms shall not be 
signed,” as it is standard not to sign 
blank order forms, and makes sev-
eral clarifications under the section 
“certification for the basis of these 
orders.”
Comments sent to Michele A. Phin-
ney, Director, Office of Regulation and 
Policy Coordination, Department of 
Health and Mental Hygiene, were ac-
cepted through September 10, 2012 . A 
public hearing has not been scheduled.
This issue of the Maryland Register 
is available at http://www.dsd.state.
md.us/MDRegister/3916.pdf .
For updates on the MOLST form 
and to download the form itself, visit 
http://marylandmolst.org/
CASE PRESENTATION
One of the regular features of this Newsletter is the presentation of a case considered by an ethics committee and an 
analysis of the ethical issues involved. Readers are both encouraged to comment on the case or analysis and to submit 
other cases that their ethics committee has dealt with. In all cases, identifying information about patients and others in the 
case should only be provided with the permission of the patient. Unless otherwise indicated, our policy is not to identify 
the submitter or institution. We may also change facts to protect confidentiality. Cases and comments should be sent to  
MHECN@law.umaryland.edu, or MHECN, Law & Health Care Program, University of Maryland Francis King Carey 
School of Law, 500 W. Baltimore St., Baltimore, MD 21201.
CASE STUDY INVOLVING A 
POSSIBLY PREGNANT DONOR
A 27 year old woman involved in 
a motor vehicle accident is declared 
dead by neurologic criteria. She had 
indicated on her driver's license that 
she wished to be an organ donor, and 
her parents have agreed (she is unmar-
ried). As the transplant surgeon pro-
ceeds with the surgery to procure her 
organs, he suspects from the size and 
feel of her uterus that she may be preg-
nant. He asks staff to check whether a 
pregnancy test was done in the emer-
gency department or intensive care 
unit; there is no record of a pregnancy 
test in her medical records. He asks a 
nurse to do a pregnancy test. The nurse 
wonders whether consent to test for 
pregnancy is required. They decide to 
call the ethics consultant on call to ask 
whether they need to get consent to do 
a pregnancy test.
COMMENTARY FROM A  
TRANSPLANT ETHICIST, 
TRANSPLANT SURGEON,  
AND ORGAN PROCUREMENT 
ORGANIZATION MEDICAL  
DIRECTOR
In this case, we have a 27 year-old 
female, who has been declared dead 
by neurologic criteria (i.e., “brain 
dead”). She has previously authorized 
donation of her organs by so designat-
ing on her driver’s license. This is a 
document of gift under the Maryland 
Revised Uniform Anatomical Gift 
Act (SB756, 2011), and although, as 
stated, her parents have agreed, the de-
cedent’s authorization is sufficient and 
binding in and of itself (see http://mlis.
state.md.us/2011rs/billfile/sb0756.
htm). 
As organ recovery begins, “the 
surgeon suspects from the size and feel 
of the uterus that she might be preg-
nant.” No pregnancy test has yet been 
performed, and when the surgeon asks 
that one be done, a nurse questions 
whether consent needs to be obtained 
for this, and an emergent ethics con-
sult is requested. The question initially 
posed to the clinical ethicist is whether 
consent is required to perform a preg-
nancy test on this donor, but to answer 
this question, we need much more 
background information regarding au-
thorization (note that I do not use the 
word “consent”) for donation, and also 
about the outcomes of pregnancies in 
brain dead individuals. Thus, if it were 
known that no brain dead individual 
had ever been artificially maintained 
(not “kept alive!”) long enough to de-
liver a live infant, then the question of 
pregnancy becomes moot. It is entirely 
possible that this knowledge base is 
not within the experience of a single 
individual, and so even if the ethics 
consult in such an emergency may be 
responded to by a single person, (s)he 
may need to reach out to others with 
the expertise necessary to provide the 
MOLST 
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factual base required for meaningful 
recommendations.
The question in this particular case is 
unusual in the sense that it is posed 
when the donor is already in the oper-
ating room, and, presumably, during 
the initial exploration of the abdominal 
cavity, which is routinely performed to 
exclude unsuspected medical problems 
that might preclude organ recovery, 
such as an undiagnosed malignancy. 
This suggests that, if pregnant, the 
donor is relatively early in her preg-
nancy, as the uterus typically is large 
enough to be felt on examination after 
twelve weeks, and reaches the level of 
the umbilicus by 20 weeks. There is 
variability across the country regard-
ing routine pregnancy testing of organ 
donors, and many organ procurement 
organizations (OPO) only obtain such 
testing in unusual circumstances, or to 
rule out particular malignancies. Obvi-
ously, it would have been preferable 
for many reasons, not least of which is 
the ability for a less rushed ethics con-
sultation, to have determined whether 
the donor was pregnant or not prior to 
the start of the donor operation. Brain 
dead individuals have been artificially 
supported for as long as 3.5 months 
to permit live birth of an infant, and 
pregnancies have resulted in live births 
from brain-dead individuals as early as 
16 weeks of gestation, so the question 
here is not irrelevant (Esmaeilzadeh, 
2010). Although organ recovery has 
begun, no irretrievable steps take place 
in the procedure until the very end, 
so, should the donor turn out to be 
pregnant, and should the decision be 
made to attempt to support the preg-
nancy, it would be possible to close 
the incisions and return the donor to 
the ICU. This would only be possible 
in the case of a heart-beating, brain 
dead organ donor. In the setting of 
DCD donation (donation after circula-
tory death), no incision is made until 
after the cardiopulmonary death of the 
donor (and a suitable 2-5 minute wait-
ing period thereafter), and by the time 
the surgeon felt the uterus, the fetus 
would no longer be viable. Similarly, 
in the instance of a brain-dead do-
nor, if the question of pregnancy was 
raised after cross-clamp and perfusion 
of the donor, there would be no option 
of “rescuing” the fetus.
Authorization for organ donation 
includes all testing necessary to deter-
mine if the subject would be a suitable 
donor, and, thus, no separate consent 
for a pregnancy test would be neces-
sary. More important, however, is the 
question of what one would do with 
the results of such testing, and what 
the ethics consultant would recom-
mend. Obviously, a negative preg-
nancy test would resolve the issue, but 
one should not order the test hoping 
for such a result until thinking through 
the course should the opposite result 
be obtained. Assuming a positive test, 
and assuming a pregnancy could pos-
sibly be carried until the fetus was vi-
able, a number of important questions 
face the ethicist. A non-exhaustive list 
of such questions might include:
1. Did the patient know she was 
pregnant?
2. If so, had she made a decision 
regarding her desired outcome 
of the pregnancy?
3. If the patient had planned to 
keep the pregnancy, would she 
make the same decision know-
ing she would not survive to 
raise the child?
4. We know she is unmarried, but 
is the putative father in the pic-
ture? Does he have an opinion, 
and does he have any rights?
5. If the parents and the father 
disagree, who prevails?
6. If the decision is made to try to 
maintain the pregnancy, does 
that preclude subsequent organ 
donation? (not necessarily)
There is rarely an issue in paus-
ing the process of organ recovery in 
a brain dead donor for a few hours, 
except in the case of a hemodynami-
cally unstable donor, in which case 
the issue of maintaining the pregnancy 
would be out of the question anyway. 
As soon as the surgeon raises the 
question, a halt should be called to 
the procedure until the ethics consult 
can be performed. Ideally, the ethicist 
should respond to the operating room, 
but a phone consultation would also 
be possible. The OPO medical direc-
tor and administrator on-call should be 
notified by the organ recovery team, 
and should participate in the discus-
sion. The clinical ethicist should also 
gather whatever experts are needed 
to help answer the medical questions, 
whether these be members of the 
hospital ethics committee, should such 
expertise reside there, or others (e.g., 
maternal-fetal medicine) as necessary. 
The ethicist must determine who is/
are the legal agents for the donor, and 
who will make the ultimate decision 
regarding the disposition of the preg-
nancy, should that turn out to be the 
issue. Hospital counsel should also be 
notified.
The ethicist, in this case, realistically 
has only 3-4 hours to complete these 
tasks. Had the donor been identified 
as pregnant prior to beginning the 
donation process, one might have days 
to more leisurely consider the options 
and ramifications. The ethicist should 
place a preliminary note in the chart, 
and a more complete note could be 
submitted, both to the hospital chart 
and to the OPO via the medical direc-
tor, at a subsequent time.





Associate Professor of Surgery
New Jersey Medical School/UMDNJ
REFERENCES:
Esmaeilzadeh M, et al. (2010). One life 
ends, another begins: Management of a 
brain-dead pregnant mother-A systemat-
ic review. BMC Med. 2010; 8:74-84.
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COMMENTARY FROM A  
TRANSPLANT ETHICIST IN 
AUSTRALIA
My first reaction when reading this 
case was, “Why wasn’t a pregnancy 
test performed before the surgeon 
opened the patient for organ procure-
ment?” [The case states: “As the 
transplant surgeon proceeds with the 
surgery to procure her organs, he 
suspects from the size and feel of her 
uterus that she may be pregnant.”] It 
is unclear if the heart and lungs have 
been removed, and now the abdominal 
team is proceeding into that cavity for 
the liver and other organs, then notic-
ing, “the size and feel of the uterus” 
being abnormal. Another possibility is 
that the surgeon has opened the wom-
an’s body and done an initial manual 
exploration of all the organs and then 
notices (before removing anything) the 
abnormal size and feel of the uterus. 
The ethicist would need to ask appro-
priate questions to determine the stag-
ing of the procurement procedure. 
Moving from those questions, I am 
troubled that the surgeon is already 
inside the patient. From an ethics 
perspective, the surgeon should not 
have ‘proceeded to surgery’ without 
knowing (by lab testing) if the patient 
was pregnant or not. The standard 
practice in my experience is for the or-
gan procurement organization (OPO) 
to obtain this laboratory result before 
surgical recovery is initiated (Council 
of Europe, 2009; Gift of Life Donor 
Program, 2009; United Network for 
Organ Sharing, 2004). Granted, how-
ever, “standard practice” varies ac-
cording to the location of practice and 
this commentary includes reflection on 
regional/national regulations (Coun-
cil of Europe, 2009; UK Transplant, 
2011). )] The surgeon then reviews all 
assay data before the donor candidate 
is surgically opened in the O.R.
But, as the ethicist receiving the 
consult request in the face of a surgeon 
whose hands are inside the patient, 
both the surgeon and I are watching 
the time-clock ticking.  Delays can 
cause irreversible organ damage put-
ting graft utility at risk [it is unclear 
from the case details if cross-clamp 
has occurred].  Because pregnancy 
testing is the standard of care [in 
European countries], and the woman 
had registered her consent to donate, 
it can be argued that her consent for 
testing pertaining to donation candi-
dacy/screening is implied. This said, 
no family consent for testing would be 
required and attempts to obtain such 
would unnecessarily delay proceed-
ings. 
My advice in this case would be to 
proceed with STAT pregnancy testing 
as this assay (β-HCG) is a routine ele-
ment of donor screening. With regard 
to results…Because the donor can-
didate is already declared brain dead 
and opened in the O.R. for procure-
ment, one has to ponder if there is a 
chance of fetal viability if the woman 
were to be closed (assuming the heart 
and lungs had not been removed) and 
continued on life-support (so as to host 
the fetus until term or near-term). The 
question should be posed and officially 
answered for the consult report.  But 
even if the heart and lungs had been 
removed, β-HCG testing should still 
be performed. Why you ask?
β-HCG testing is also pertinent to 
matters of oncology, not just preg-
nancy. Specifically, this assay also can 
act as a tumor marker in some types of 
cancer, including ovarian, liver, stom-
ach, and lung cancers. So just because 
this test was missed at case onset, and 
the woman is likely not able to bear a 
pregnancy to term under the current 
conditions, the assay may have value 
in that it could yield data that indicates 
she should not be a donor (if she has 
a malignancy) (Council of Europe, 
2009). This is an important topic for 
the ethicist to include in the consult 
report because it pertains to the matter 
of preventing harm to future patients 
(through preventing disease transmis-
sion). 
[NOTE: if pregnancy was confirmed 
after her heart and lungs had been 
removed (one of the case stagings pro-
posed) then there is potential legal risk 
for the OPO in their failure to rule out 
pregnancy before organ procurement 
was initiated. See further discussion 
below about brain-dead women car-
rying fetuses to term on life support. 
The ethicist should consult a medical 
malpractice attorney for information 
on fetal duties and fetal harm – is the 
fetus a “patient”? Is this a medical er-
ror to the deceased, a non-patient? An 
error to the fetus? What legal obliga-
tions are there for the OPO?]
Responding to the O.R. the ethicist 
should write a preliminary consult 
note in the OPO donor chart; but if not 
feasible, the guidance can be called to 
the O.R. telephonically. A full consult 
report should be given to the surgeon 
who requested the consult asap. This 
surgeon is also likely employed by 
the OPO and thus it would be prudent 
for the medical director of the OPO 
to also receive a copy of the report. 
(Note: as a matter of collegiality, the 
medical director should also be noti-
fied of the consult request, though 
they are already likely aware of the 
matter per their own procedural rules). 
It is important for the OPO medical 
director to receive a copy of the ethics 
consult report because this individual 
needs to be aware of procedural mis-
steps so that case review and correc-
tive action is undertaken on an organi-
zational level. Additionally, as an aid 
to the surgeon and OPO, the ethicist 
should include bioethics and regula-
tory references as appropriate. These 
can be a great teaching tool, as well as 
a source of integrity for advice given 
in the report.
As an aside, if organ procurement 
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had not already been started; that is, 
the woman was still on life support 
and her body had not been surgically 
opened, the case might take a differ-
ent turn. β-HCG testing would still be 
performed as standard procedure for 
donor screening (again, depending on 
regional practice variations), and posi-
tive results would then be reviewed 
with the patient’s surrogate to explore 
the woman’s values about pregnancy 
and motherhood. Did the woman 
know she was pregnant? Perhaps 
she did but her family or unmarried 
partner did not know. Did the woman 
desire to continue her pregnancy? 
Perhaps she was still deciding about 
this matter? Perhaps she decided to 
terminate the pregnancy but had not 
yet done so. Perhaps she would have 
wanted to carry the child to term? If 
the latter, and there is family willing 
to raise and support the child, continu-
ing the mother on life-support with 
the intent to deliver the child could be 
posed (the ethicist should not exclude 
the possibility that though unmar-
ried, the woman might have been in 
a long-term relationship with a man 
or a woman and not married to her 
partner). The psychosocial issues 
would need deep exploration and the 
assistance of a social worker would 
be of great aid to the ethics consulta-
tion.  According to Esmaeilzadeh et 
al. (2010), “The important question 
is from which gestational age onward 
should the pregnancy be supported? 
At present, it seems that there is no 
WHAT, AND WHERE, TO DOCUMENT?
In the second edition of the Core Competencies for Health Care Ethics Consultation (ASBH CC TF, 2011), 
“emerging process standards” were added to identify best practices for ethics consultation. The Task Force that 
updated the Core Competencies recognized that ethics consultants may respond to a range of requests, but a 
request involving an active patient is given special status due to the more direct potential to help or harm stake-
holders based on the consultant’s involvement. For ethics consultations involving an active patient, the attending 
physician and patient (or family) should be notified about the consultation, and the consultation should be docu-
mented in the patient’s medical record, in addition to the ethics consultation service’s internal records. 
Dubler and colleagues (2009, p. 26) wrote: “A formal note in the medical record, such as a typed note in the 
chart, is the standard method care providers use to communicate about all aspects of the patient’s care.” Should 
the ethics consultation featured in this case study be documented in the patient’s medical record? Should the 
patient’s family be notified about the consultation? One might argue that because the patient is dead, there should 
be no family notification of the consultation nor documentation in the medical record. Recommendations at this 
point do not affect health care decisions for this patient, so some would argue they don’t belong in the patient’s 
chart. Instead, an analysis of the case should be given to the involved staff (both at the hospital and the Organ 
Procurement Organization). 
In addition, the ethics consultant(s) should follow up on the policy issue of whether pregnancy testing should be 
established as a standard procedure pre-organ procurement if not already done in the clinical setting. This case 
clearly has implications beyond the question posed to the consultant: “Can we test the patient for pregnancy with-
out consent?”




American Society for Bioethics & Humanities' Core Competencies Update Task Force [ASBH CC TF]. (2011). Core Com-
petencies for Health Care Ethics Consultation: The Report of the American Society for Bioethics and Humanities (2nd Ed.). 
Glenview, IL: American Society for Bioethics & Humanities.
Dubler, NN, Webber, MP, Swiderski, DM, et al. (2009). Charting the future: Credentialing, privileging, quality, and evalua-
tion in clinical ethics consultation. Hastings Center Report, 6, 23-33.
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clear lower limit to the gestational 
age which would restrict the physi-
cian's efforts to support the brain-dead 
mother and her fetus.” There is still the 
potential for the mother’s organ/tissue 
donation to occur after childbirth.
If the results are not pregnancy, but 
rather cancer, one could argue that 
the next of kin should be told of those 
results if there is the potential for that 
type of cancer to be genetic (i.e., other 
family members might also need to be 
tested).
As always, there is an ethical duty 
to recognize that scope of practice is-
sues apply. Due to the complexity and 
time sensitivity of this case, it should 
be handled by a professional medical 
ethicist rather than a hospital ethics 
committee (the latter group will likely 
not be prepared to handle it unless 
it is staffed with an on-call medical 
ethicist). 
Katrina A. Bramstedt, PhD
Clinical Ethicist
Associate Professor





Council of Europe. Guide to safety and 
quality assurance for the transplanta-
tion or organs, tissues and cells. Ad-
dendum 2009: Criteria for preventing 
the transmission of neoplastic diseases 
in organ donation. Available at http://
book.coe.int/ftp/3311.pdf Accessed 6 
Aug 2012.
Gift of Life Donor Program, New Jer-
sey Sharing Network. Organ & Tissue 
Donation: The New Jersey Hero Act & 
Your Role Two Organ Procurement Or-
ganizations Work With New Jersey Hos-
pitals (2009). Available at http://ccoe.
umdnj.edu/HeroesAct/tools_resources/
UMDNJ_NurseCurriculumn_2009%20
final.pdf Accessed 7 Aug 2012.
United Network for Organ Sharing. 
Critical Pathway for Donation After 
Cardiac Death (2004). Available at 
http://www.unos.org/docs/Critical_Path-
way_DCD_Donor.pdf. Accessed 6 Aug 
2012.
UK Transplant (2011). NHS Blood and 
Transplant: Guidelines for Testing for 
Pregnancy in Deceased Potential Solid 
Organ Donors.  http://www.nhsbt.nhs.
uk/downloads/board_papers/mar10/
guidelines_for_testing.pdf Accessed 6 
Aug 2012
Esmaeilzadeh M, et al. (2010). One life 
ends, another begins: Management of a 
brain-dead pregnant mother-A system-




The Role of Patient Satisfaction: What Does it Mean for Health Care? The New York Academy of Medicine, 1216 Fifth 
Avenue at 103rd Street, New York, NY. For more information, visit http://www.nyam.org/events/2012/2012-10-01.html .
10 (2-5P) 
Albert R. Jonsen Bioethics Symposium: The Journey of Bioethics: Past, Present, and Future. A Roundtable with Prominent 
Figures in Bioethics. The City Club, 155 Sansome Street, San Francisco, CA. For more information, visit: http://www.
cpmc.org/services/ethics/events.html
11-12 
The 10th Annual Conference on Contemporary Catholic Healthcare Ethics End of Life Care & Institutional Identity in the 
Catholic Tradition. Loyola University Chicago Stritch School of Medicine, Maywood, Illinois. For more information, visit: 
http://bioethics.lumc.edu/news_and_events/CHA_2012.html 
11-12 
International Neuroethics Conference, sponsored by the International Neuroethics Society. New Orleans Marriot, New 
Orleans, LA. For more information, visit: http://www.neuroethicssociety.org/2012-annual-meeting 
18-21 
“Representing Bioethics:” Annual Meeting of the American Society for Bioethics and Humanities. Hyatt Regency on Capi-
tol Hill, Washington, DC. For more information, visit http://www.asbh.org. 
24 (4-6P) 
Politics of Assistive Technology: The Case of 20th Century Reading Machines. Speaker: Mara Mills, Ph.D., Assistant Pro-
fessor, Media, Culture & Communication, New York University. Sponsored by Penn Center for Bioethics. 3401 Market St, 
Suite 321, Philadelphia, PA. For more information, visit: http://www.bioethics.upenn.edu/Colloquium.shtml 
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23-25 
Brain Matters 3 “Values at the Crossroads of Neurology, Psychiatry & Psychology.” Marriott Cleveland Downtown at Key 




Reproductive Justice: The New Constitutional Battle Front. Stuart Rome Lecture at the University of Maryland King Carey 
School of Law. Ceremonial Moot Court Room, 500 West Baltimore Street, Baltimore, MD. For more information, visit: 
http://www.law.umaryland.edu/calendar/ 
2 
Institutional Financial Conflicts of Interest in Research Universities. Wasserstein, Milstein Conference Rooms, Harvard 
Law School, Cambridge, MA. For more information, visit: http://http://www.law.harvard.edu/programs/petrie-flom/events/
conferences/fcoi/index.html
2-5 
Clinical Ethics Immersion, sponsored by the Center for Ethics at Washington Hospital Center, MedStar Washington Hospi-
tal Center, Washington, D.C. For more information, visit: whcenter.org/ethics
9 




The Body Politic: The Battle Over Science in America. Penn Center for Bioethics Conversation Series featuring Jonathan 
Moreno, PhD (book author) and Arthur Caplan, PhD. Sponsored by Penn Center for Bioethics. 3401 Market St, Suite 321, 
Philadelphia, PA. For more information, visit: http://www.bioethics.upenn.edu/Colloquium.shtml.
JANUARY
10 (4-6P) 
What do we do about low-value medical services? Speaker: Ezekiel J. Emanuel, M.D., Ph.D., University of Pennsylvania. 




5th Annual Medicine and the Humanities and Social Sciences Conference, Sam Houston State University  College of Hu-
manities and Social Science,  Huntsville, TX. For more information, visit: http://www.shsu.edu/~hss001/conference/ 
15 (4-6P) 
Upcoming revolution in prenatal testing. Speaker: Vardit Ravitsky, Ph.D., Bioethics Program, University of Montreal. 
Sponsored by Penn Center for Bioethics. 3401 Market St, Suite 321, Philadelphia, PA. For more information, visit: http://
www.bioethics.upenn.edu/Colloquium.shtml
More than 200 people attended (and over 500 viewed the live webcast) of the July 27-28, 2012  
conference, The Thin Ethical Line: When Professional Boundaries and Personal Interests Collide, 
sponsored by the Treuman Katz Center for Pediatric bioethics at Seattle Children’s Hospital. Free 
webcasts are available at www.seattlechildrens.org/bioethics.
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